» Articles » PMID: 30221102

Measuring Social Function in Diverse Cancer Populations: Evaluation of Measurement Equivalence of the Patient Reported Outcomes Measurement Information System (PROMIS) Ability to Participate in Social Roles and Activities Short Form

Overview
Date 2018 Sep 18
PMID 30221102
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Conceptual and psychometric measurement equivalence of self-report questionnaires are basic requirements for valid cross-cultural and demographic subgroup comparisons. The purpose of this study was to evaluate the psychometric measurement equivalence of a 10-item PROMIS Social Function short form in a diverse population-based sample of cancer patients obtained through the Measuring Your Health (MY-Health) study ( = 5,301). Participants were cancer survivors within six to 13 months of a diagnosis of one of seven cancer types, and spoke English, Spanish, or Mandarin Chinese. They completed a survey on sociodemographic and clinical characteristics, and health status. Psychometric measurement equivalence was evaluated with an item response theory approach to differential item functioning (DIF) detection and impact. Although an expert panel proposed that many of the 10 items might exhibit measurement bias, or DIF, based on gender, age, race/ethnicity, and/or education, no DIF was detected using the study's standard DIF criterion, and only one item in one sample comparison was flagged for DIF using a sensitivity DIF criterion. This item's flagged DIF had only a trivial impact on estimation of scores. Social function measures are especially important in cancer because the disease and its treatment can affect the quality of marital relationships, parental responsibilities, work abilities, and social activities. Having culturally relevant, linguistically equivalent and psychometrically sound patient-reported measures in multiple languages helps to overcome some common barriers to including underrepresented groups in research and to conducting cross-cultural research.

Citing Articles

Health utility scores of six common cancers in China measured by SF-6Dv2.

Tao Y, Cao Y, Xu L, Shi J, Leng L, Yang H Health Qual Life Outcomes. 2025; 23(1):5.

PMID: 39799326 PMC: 11725192. DOI: 10.1186/s12955-025-02332-8.


Validation of a Core Patient-Reported Outcome Measure for Life Participation in Kidney Transplant Recipients: the SONG Life Participation Instrument.

Jaure A, Vastani R, Teixeira-Pinto A, Ju A, Craig J, Viecelli A Kidney Int Rep. 2024; 9(1):87-95.

PMID: 38312789 PMC: 10831350. DOI: 10.1016/j.ekir.2023.10.018.


Patient Priorities-Aligned Care for Older Adults With Multiple Conditions: A Nonrandomized Controlled Trial.

Tinetti M, Hashmi A, Ng H, Doyle M, Goto T, Esterson J JAMA Netw Open. 2024; 7(1):e2352666.

PMID: 38261319 PMC: 10807252. DOI: 10.1001/jamanetworkopen.2023.52666.


Design and methods of a randomized telehealth-based intervention to improve fitness in survivors of childhood cancer with exercise intolerance.

Maharaj A, Jefferies J, Mulrooney D, Armstrong G, Brinkman T, ONeil S Contemp Clin Trials. 2023; 133:107339.

PMID: 37730199 PMC: 10591872. DOI: 10.1016/j.cct.2023.107339.


Preferences for Participation Measurement Among Individuals Diagnosed With Cancer: A Qualitative Content Analysis.

LHotta A, Varughese T, Lyons K, Trebelhorn A, Manohar A, King A OTJR (Thorofare N J). 2023; 44(2):244-254.

PMID: 37354019 PMC: 10748790. DOI: 10.1177/15394492231181104.


References
1.
Stewart A . Health-related quality-of-life assessments in diverse population groups in the United States. Med Care. 2000; 38(9 Suppl):II102-24. View

2.
Taskila T, de Boer A, van Dijk F, Verbeek J . Fatigue and its correlates in cancer patients who had returned to work--a cohort study. Psychooncology. 2010; 20(11):1236-41. DOI: 10.1002/pon.1843. View

3.
Bloom J, Petersen D, Kang S . Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology. 2007; 16(8):691-706. DOI: 10.1002/pon.1208. View

4.
Whiteneck G . Issues affecting the selection of participation measurement in outcomes research and clinical trials. Arch Phys Med Rehabil. 2010; 91(9 Suppl):S54-9. DOI: 10.1016/j.apmr.2009.08.154. View

5.
Ware Jr J, Brook R, Davies A, Lohr K . Choosing measures of health status for individuals in general populations. Am J Public Health. 1981; 71(6):620-5. PMC: 1619843. DOI: 10.2105/ajph.71.6.620. View